Krop Julie has filed 3 insider transactions across 2 companies since June 2024.
Most recent transaction: a grant/award of 450000 shares of DiaMedica Therapeutics Inc. ($DMAC) on August 11, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 11, 2025 | DiaMedica Therapeutics Inc. | $DMAC | Krop Julie | Chief Marketing Officer | A | Stock Option (right to buy) | 450000 | $0.00 | 450,000.0000 | 42,855,660 | 9999.99% | 1.05% |
| June 11, 2025 | Aquestive Therapeutics, Inc. | $AQST | Krop Julie | Not found | A | Stock Option (Right to Purchase) | 42000 | $3.41 | 42,000.0000 | 98,871,369 | 9999.99% | 0.04% |
| June 20, 2024 | Aquestive Therapeutics, Inc. | $AQST | Krop Julie | Not found | A | Stock Option (Right to Purchase) | 38000 | $0.00 | 38,000.0000 | 0 | 9999.99% | 0.00% |